LPL Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,000
Closed -$210K 5549
2025
Q1
$210K Sell
1,000
-14,200
-93% -$2.76M ﹤0.01% 4842
2024
Q4
$2.7M Buy
+15,200
New +$2.79M ﹤0.01% 2591
2021
Q2
Sell
-2,700
Closed -$292K 4220
2021
Q1
$292K Buy
+2,700
New +$289K ﹤0.01% 3480
2020
Q3
Sell
-2,500
Closed -$245K 3546
2020
Q2
$245K Buy
+2,500
New +$220K ﹤0.01% 2983
2020
Q1
Sell
-2,700
Closed -$239K 3203
2019
Q4
$239K Buy
+2,700
New +$224K ﹤0.01% 2958
2019
Q3
Sell
-15,000
Closed -$1.09M 3287
2019
Q2
$1.09M Buy
+15,000
New +$1.18M ﹤0.01% 1660
2018
Q2
Sell
-8,100
Closed -$767K 3207
2018
Q1
$767K Sell
8,100
-500
-6% -$54.9K ﹤0.01% 1809
2017
Q4
$832K Buy
+8,600
New +$811K ﹤0.01% 1669

Other funds holding ABBV

LPL Financial's ABBV Position: Q2 2026 in Review

LPL Financial increased its AbbVie (ABBV) stake by 3.8% in Q2 2026, buying an estimated $32.5M and bringing the position to 4,096,323 shares worth $1.03B. The position accounts for 0.23% of the portfolio, ranked #88.

LPL Financial first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LPL Financial held 4,096,323 shares of AbbVie worth $1.03B as of Q2 2026.
  • LPL Financial bought 151,057 AbbVie shares in Q2 2026, an estimated $32.5M.
  • AbbVie made up 0.23% of LPL Financial's portfolio in Q2 2026, its #88 holding.
  • LPL Financial first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.